All Stories

  1. Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study

    Article • American Journal of Hematology, October 2025, Wiley

    Dr. Oscar Borsani

  2. CHEK2 Germline Variants in Early‐Onset and Familial Myeloproliferative Neoplasms

    Article • American Journal of Hematology, September 2025, Wiley

    Dr. Oscar Borsani

  3. Germline MPL mutations may be a rare cause of “triple-negative” thrombocytosis

    Article • Experimental Hematology, January 2024, Elsevier

    Dr. Oscar Borsani

  4. COVID-19 in Patients with Hematologic Diseases

    Article • Biomedicines, November 2022, MDPI AG

    Dr. Oscar Borsani

  5. Wandering Spleen: an unusual cause of recurrent abdominal pain

    Article • Clinical Gastroenterology and Hepatology, November 2022, Elsevier

    Dr. Oscar Borsani

  6. Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms

    Article • eJHaem, March 2022, Wiley

    Dr. Oscar Borsani

  7. Isolated congenital asplenia: An overlooked cause of thrombocytosis

    Article • American Journal of Hematology, March 2022, Wiley

    Dr. Oscar Borsani

  8. Autoantibodies against Type I IFNs in Patients with Ph-negative Myeloproliferative Neoplasms

    Article • Blood, January 2022, American Society of Hematology

    Dr. Oscar Borsani

  9. Eradication of Measurable Residual Disease in AML: A Challenging Clinical Goal

    Article • Cancers, June 2021, MDPI AG

    Dr. Oscar Borsani

  10. Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts

    Article • Neurology Neuroimmunology & Neuroinflammation, January 2021, Wolters Kluwer Health

    Dr. Oscar Borsani

  11. Immune Escape after Hematopoietic Stem Cell Transplantation (HSCT): From Mechanisms to Novel Therapies

    Article • Cancers, December 2019, MDPI AG

    Dr. Oscar Borsani

  12. Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls

    Article • Journal of NeuroVirology, December 2019, Springer Science + Business Media

    Dr. Oscar Borsani

  13. Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment

    Article • Journal of Oncology, August 2019, Hindawi Publishing Corporation

    Dr. Oscar Borsani

  14. Stormorken Syndrome Caused by a p.R304W STIM1 Mutation: The First Italian Patient and a Review of the Literature

    Article • Frontiers in Neurology, October 2018, Frontiers

    Dr. Oscar Borsani

  15. Endosteal vessel integrity: a new therapeutic goal in acute myeloid leukemia?

    Article • October 2018, AME Publishing Company

    Dr. Oscar Borsani

  16. Hepatic iron is the major determinant of serum ferritin in NAFLD patients

    Article • Liver International, July 2017, Wiley

    Luca Valenti, Dr. Oscar Borsani